Anaveon Announces Presentation of Positive ANV600 Clinical Data at ASCO 2026 and Actively Seeks Partners for its Legacy Oncology Portfolio
BASEL, Switzerland, May 11, 2026 (GLOBE NEWSWIRE) -- Anaveon, a late-stage preclinical…
Amplia Therapeutics and Australia New Zealand Gynaecological Oncology Group (Anzgog) Announce Ovarian Cancer Study
May 08, 2026 20:45 ET | Source: Amplia Therapuetics Limited Melbourne, Australia,…
BostonGene Receives Frost & Sullivan’s 2026 Global Company of the Year for Advancing in AI-Driven Multimodal Oncology Platforms
Recognition highlights BostonGene's leadership in improving drug development decisions,reducing risk and accelerating patient…
Laigo Bio completes final close of oversubscribed seed financing of 17 million co-led by Biovance Capital and Kurma Partners to advance oncology and auto-immunity programs
Additional funding of €4m from new co-lead investor Biovance Capital, and €1.5m…
Servier and Day One Biopharmaceuticals announce acquisition to expand Servier’s rare oncology portfolio
Acquisition positions Servier as a leader in pediatric low-grade glioma and expands…
Persevere Therapeutics Launches as a Clinical-Stage Oncology Company with a Novel Phase 1b/2a Agent and Announces First Close of Seed Financing
Chesterbrook, PA, March 03, 2026 (GLOBE NEWSWIRE) -- Persevere Therapeutics, Inc. (“Persevere”),…
Cardiff Oncology Reports Full Year 2025 Results and Provides Business Update
February 24, 2026 16:30 ET | Source: Cardiff Oncology, Inc. Reported positive…
Coherus Oncology, Inc. Announces Pricing of Public Offering of Common Stock
February 12, 2026 21:18 ET | Source: Coherus Oncology, Inc. REDWOOD CITY,…
Memorial ili Hospital Earns EARL Theranostics Center of Excellence for Nuclear Oncology Treatments
ISTANBUL, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Memorial Şişli Hospital’s (part of…
Daiichi Sankyo Unveils New Toronto Headquarters to Accelerate Investment and Innovation in Oncology
Investment in Canadian headquarters fuels expansion of Canadian operations, advancing access to…
